CoChat

Effects of Regular Kefir Consumption on Gut Microbiota in Patients with Metabolic Syndrome: A Parallel-Group, Randomized, Controlled Study

Open access
BELLIKCI-KOYU, Ezgi, SARER-YUREKLI, Banu Pınar, AKYON, Yakut, AYDIN-KOSE, Fadime, KARAGOZLU, Cem, OZGEN, Ahmet Gokhan, BRINKMANN, Annika, NITSCHE, Andreas, ERGUNAY, Koray, YILMAZ, Engin, BUYUKTUNCER, Zehra · 2019 · Nutrients

The DOI matches its Crossref record; 84 of the 86 references it cites were found in a registry or an index; 5 of the 21 sources its claims cite were checked for support.

Abstract

Several health-promoting effects of kefir have been suggested, however, there is limited evidence for its potential effect on gut microbiota in metabolic syndrome This study aimed to investigate the effects of regular kefir consumption on gut microbiota composition, and their relation with the components of metabolic syndrome. In a parallel-group, randomized, controlled clinical trial setting, patients with metabolic syndrome were randomized to receive 180 mL/day kefir (n = 12) or unfermented milk (n = 10) for 12 weeks. Anthropometrical measurements, blood samples, blood pressure measurements, and fecal samples were taken at the beginning and end of the study. Fasting insulin, HOMA-IR, TNF-α, IFN-γ, and systolic and diastolic blood pressure showed a significant decrease by the intervention of kefir (p ≤ 0.05, for each). However, no significant difference was obtained between the kefir and unfermented milk groups (p > 0.05 for each). Gut microbiota analysis showed that regular kefir consumption resulted in a significant increase only in the relative abundance of Actinobacteria (p = 0.023). No significant change in the relative abundance of Bacteroidetes, Proteobacteria or Verrucomicrobia by kefir consumption was obtained. Furthermore, the changes in the relative abundance of sub-phylum bacterial populations did not differ significantly between the groups (p > 0.05, for each). Kefir supplementation had favorable effects on some of the metabolic syndrome parameters, however, further investigation is needed to understand its effect on gut microbiota composition.

Overview

CoChat Summary

## TL;DR

This randomized controlled study tested 12 weeks of kefir (180 mL/day) versus unfermented milk in adults with metabolic syndrome and found some within-group improvements in insulin resistance, inflammatory markers, blood pressure, and gut microbiota, but no significant differences between groups for these outcomes. Kefir significantly increased only the relative abundance of Actinobacteria (p = 0.023), while overall diversity measures and most microbiota changes were not significant.

## Key findings

  • A total of 22 participants completed the trial after randomization of 40 eligible participants; 12 received kefir and 10 received unfermented milk.
  • After 12 weeks, kefir was associated with significant within-group decreases in fasting insulin and HOMA-IR (p = 0.050), TNF-α (p = 0.015), IFN-γ (p = 0.013), systolic BP (p = 0.041), and diastolic BP (p = 0.019), but these improvements were not significant versus the milk group.
  • Gut microbiota analysis showed a significant increase only in Actinobacteria with kefir (p = 0.023); no significant change was observed for Bacteroidetes, Proteobacteria, or Verrucomicrobia.
  • No significant differences were found between groups in alpha/beta diversity metrics, OTU counts, Firmicutes/Bacteroidetes ratio, or changes in sub-phylum taxa; no side effects were reported.

## Methods

  • Parallel-group, randomized, controlled clinical trial in adults aged 18–65 years with metabolic syndrome, recruited from Ege University outpatient clinic; trial ran from March 2015 to July 2017 and was registered as NCT03966846.
  • Participants were randomized to kefir (180 mL/day, n = 12) or unfermented milk (180 mL/day, n = 10) for 12 weeks; diets and physical activity were intended to remain habitual.
  • Outcomes included 24-h dietary recalls, anthropometry, fasting blood biomarkers, blood pressure, fecal 16S rRNA sequencing of the V3-V4 region, and statistical comparisons/correlations using tests including Kruskal–Wallis, Mann–Whitney U, Spearman, and PERMANOVA.

## Limitations

  • The paper states that it examined only microbiota composition, not microbiota functionality; it says that metabolite-based markers could have improved interpretation and calls this the main limitation.
  • The paper states that the small number of participants in each arm is another limitation.
  • Evident from the text: despite randomization, the final sample was small (22 completers), which limits precision and makes between-group comparisons underpowered.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.3390/nu11092089

Cites

84 of 84 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Figures

Figure 1 Timeline of the study.
Figure 1 Timeline of the study.CC BY · PubMed Central
Figure 2 Gut microbiota composition before and after the intervention in each group.
Figure 2 Gut microbiota composition before and after the intervention in each group.CC BY · PubMed Central
Figure 3 Bacterial changes in the relative abundance of Bacteriodetes (a) and Firmucutes (b) by the consumption of test drinks.
Figure 3 Bacterial changes in the relative abundance of Bacteriodetes (a) and Firmucutes (b) by the consumption of test drinks.CC BY · PubMed Central
Figure 4 Box–and–whisker plots of the alpha diversity metrics calculated for the study groups. The box represents the median and the interquartile range, whereas whiskers indicate the 90th and 10th percentiles (A: Observed OTUs, B: Shannon index, C: Faith phylogenetic diversity index).
Figure 4 Box–and–whisker plots of the alpha diversity metrics calculated for the study groups. The box represents the median and the interquartile range, whereas whiskers indicate the 90th and 10th percentiles (A: Observed OTUs, B: Shannon index, C: Faith phylogenetic diversity index).CC BY · PubMed Central
Figure 5 Principal coordinate analysis (PCoA) plot of the unweighted (A) and weighted (B) UniFrac distance matrices in the study groups. The plots were generated using EMPeror [36]. Axis titles indicate the percentage variations. The colors indicate sampling time (red: week 0, blue: week 12).
Figure 5 Principal coordinate analysis (PCoA) plot of the unweighted (A) and weighted (B) UniFrac distance matrices in the study groups. The plots were generated using EMPeror [36]. Axis titles indicate the percentage variations. The colors indicate sampling time (red: week 0, blue: week 12).CC BY · PubMed Central

Verification

Claims the paper makes

4 Valid · 0 Not valid · 6 Not checked · 75 Own results and interpretations

41 more claims

Create a free account to see all 85 claims and to verify the 4 references still open.

See all claims — free account
  • It may state two separate claims as one. 31
  • Probably not a substantial claim. 14
  • The quote only partly states this claim. 1

Create a free account to see these claims.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 84 references

Research works printed but not linked: 1

  1. Koyu, 2018, A functional food: Kefir, J. Nutr. Diet., 46, 166

Cited by

See all 144

Metadata

Authors
BELLIKCI-KOYU, E., SARER-YUREKLI, B. P., AKYON, Y., AYDIN-KOSE, F., KARAGOZLU, C., OZGEN, A. G., BRINKMANN, A., NITSCHE, A., ERGUNAY, K., YILMAZ, E., & BUYUKTUNCER, Z.
Affiliations
  • Department of Nutrition and Dietetics, Faculty of Health Sciences, Hacettepe University, Ankara 06230, Turkey
  • Ege University (TR)
  • Department of Medical Microbiology, Faculty of Medicine, Hacettepe University, Ankara 06230, Turkey
  • Department of Biochemistry, Faculty of Pharmacy, Ege University, Izmir 35040, Turkey
  • Department of Dairy Technology, Faculty of Agriculture, Ege University, Izmir 35040, Turkey
  • Department of Endocrinology, Faculty of Medicine, Ege University, Izmir 35040, Turkey
  • Robert Koch Institute (DE)
  • Department of Medical Biology, Acıbadem Mehmet Ali Aydınlar University, Istanbul 34752, Turkey
Venue
Nutrients
Publisher
MDPI AG
Published
2019-09-04
Volume
11
Issue
9
Pages
2089
ISSN
2072-6643 (ISSN-L)
OpenAlex
W2971933675
Cited by
144
References
86
Citations by year
2026: 15 · 2025: 22 · 2024: 24 · 2023: 25 · 2022: 21 · 2021: 22 · 2020: 14 · 2019: 1
FWCI
4.80
Type
journal article
Language
en
Open access
Locations
  • Nutrients (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • Acibadem University Open Access Repository (submittedVersion)
  • Publication server of the Robert Koch Institute (Robert Kock Institute) (submittedVersion, cc-by)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
  • Hacettepe University Institutional Repository (hacettepe.edu.tr) (submittedVersion, cc-by)
Funders
Turkish Council of Higher Education (XX)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
  • Life Sciences › Agricultural and Biological Sciences › Food Science › Probiotics and Fermented Foods
  • Health Sciences › Nursing › Nutrition and Dietetics › Infant Nutrition and Health
Keywords
kefir, gut microbiota, metabolic syndrome, fermented milk, insulin resistance, fasting insulin, HOMA-IR, blood pressure, TNF-α, interferon-gamma, actinobacteria, Bacteroidetes, Proteobacteria, Verrucomicrobia, probiotics
MeSH terms
Gastrointestinal Microbiome, Kefir, Adolescent, Adult, Aged, Blood Glucose, Body Weight, Female, Humans, Lipids, Male, Middle Aged, Phylogeny, Metabolic Syndrome, Young Adult

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

The claim verdicts this report counts are experimental: their accuracy is not yet measured.

A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Cited sources are checked with a language model’s help (qwen3.8-omni-flash and gpt-6-sol).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Effects of Regular Kefir Consumption on Gut Microbiota in Patients with Metabolic Syndrome: A Parallel-Group, Randomized, Controlled Study. https://app.cochat.ai/papers/10.3390/nu11092089
The paper
BELLIKCI-KOYU, E., SARER-YUREKLI, B. P., AKYON, Y., AYDIN-KOSE, F., KARAGOZLU, C., OZGEN, A. G., BRINKMANN, A., NITSCHE, A., ERGUNAY, K., YILMAZ, E., & BUYUKTUNCER, Z. (2019). Effects of Regular Kefir Consumption on Gut Microbiota in Patients with Metabolic Syndrome: A Parallel-Group, Randomized, Controlled Study. Nutrients. https://doi.org/10.3390/nu11092089

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.